Nov 9, 2023 05:57PM
Nov 9, 2023 04:05PM
Aug 11, 2023 07:00AM
May 11, 2023 07:01AM
Mar 2, 2023 07:01AM
Jan 6, 2023 07:02AM
Jan 6, 2023 07:01AM Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Nov 30, 2022 07:02AM
Nov 30, 2022 07:01AM
Nov 15, 2022 04:25PM
Nov 15, 2022 04:25PM
Nov 3, 2022 07:01AM
Oct 4, 2022 07:01AM
Aug 24, 2022 08:01AM Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Aug 18, 2022 04:32PM
Aug 18, 2022 04:05PM
Aug 4, 2022 07:01AM
Jun 2, 2022 08:59AM
Jun 2, 2022 08:59AM
May 5, 2022 09:28AM
May 5, 2022 09:28AM Aeglea BioTherapeutics Announces $45 Million Registered Direct Offering Priced at a Premium to Market
May 5, 2022 06:30AM
Apr 12, 2022 06:01AM
Apr 12, 2022 06:01AM
Apr 11, 2022 04:31PM
Apr 11, 2022 04:30PM
Mar 8, 2022 07:02AM
Mar 8, 2022 07:01AM Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Program Updates
Feb 10, 2022 09:30AM
Feb 10, 2022 09:29AM
Feb 9, 2022 04:01PM
Feb 9, 2022 04:01PM
Dec 6, 2021 06:31AM
Dec 6, 2021 06:30AM
Nov 16, 2021 07:02AM Aeglea BioTherapeutics (AGLE) Appoints Hunter C. Smith to its Board
Nov 16, 2021 07:01AM
Nov 4, 2021 07:01AM
Nov 4, 2021 06:59AM
Aug 5, 2021 08:30AM
Jul 15, 2021 08:30AM
Jul 14, 2021 04:35PM
Jul 14, 2021 04:30PM Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Me
Jul 8, 2021 08:30AM
Jul 8, 2021 08:30AM
Jun 24, 2021 08:30AM
Jun 22, 2021 08:33AM
Jun 22, 2021 08:30AM
May 10, 2021 08:30AM
May 6, 2021 08:30AM Aeglea BioTherapeutics Launches THINK ARGININE™, a Disease Education Initiative to Improve Awareness and Diagnosis of Arginase 1 Deficiency
May 3, 2021 08:33AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All